Generic Name: Recombinant Human Interleukin-11 (IL-11)

Therapeutic Segment: Hematopoietic Growth Factor

Indications:
Indicated for the prevention of severe thrombocytopenia and the reduction of the need for platelet transfusions following myelosuppressive chemotherapy in adult patients with nonmyeloid malignancies who are at high risk of severe thrombocytopenia.

Strengths: 1.5mg & 3mg 

Pack Size: 1's